I am uniquely positioned to contribute to the health policy conversations by sharing my experience and expertise in the following topics:
Drug Pricing (Inflation Reduction Act, Medicare Drug Price Negotiation Program, Section 804 Importation Program)
Real World Evidence (electronic health records, claims database analyses, chart reviews)
Market Access (Health Technology Assessments)
Health Economics and Outcomes Research (unmet need, treatment patterns, economic evaluations, cost-effectiveness, budget impact)
Speaking Engagements
-
Opportunities to use EHR-derived RWE to inform HTA decision-making
-
Using EHR-derived real-world data for HTA decision-making and market access
-
Utilizing RWE to gain payer-trust and market access
-
RWE, Market Access, Pricing & Reimbursement World congress 2023 Americas.
https://www.rwe-marketaccess.com/
Philadelphia, USA (22nd - 23rd June 2023)
-
How to turn big messy data into structured evidence
Real-World External Data Conference: Leveraging registries & novel external data sources, AI & big data, to achieve groundbreaking real world insights
Online Conference (23 May 23, 2023)